# Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment

> **NCT02967874** · PHASE1,PHASE2 · COMPLETED · sponsor: **Russian Academy of Medical Sciences** · enrollment: 27 (actual)

## Conditions studied

- Osteoarthritis
- Joint Disease
- Osteoarthritis,Knee
- Arthritis, Degenerative
- Osteoarthrosis
- Osteoarthrosis Deformans

## Interventions

- **PROCEDURE:** Intra-articular auto-SVFs injection
- **DRUG:** Hyaluronic Acid

## Key facts

- **NCT ID:** NCT02967874
- **Lead sponsor:** Russian Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-06
- **Final completion:** 2019-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967874, "Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT02967874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*